Literature DB >> 22247960

It's time for gene therapy to get disruptive!

James M Wilson1.   

Abstract

Mesh：

Year:  2012        PMID： 22247960     DOI： 10.1089/hum.2011.2530

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  3 in total

1.  The ASGCT in 2012: Charting a Path to Bring Novel Biologic Therapies to the Clinic.

Authors:  Xandra O Breakefield
Journal:  Mol Ther       Date:  2016-12-06       Impact factor: 11.454

2.  Challenges in the gene therapy commercial ecosystem.

Authors:  Rahul Kapoor; Thomas Klueter; James M Wilson
Journal:  Nat Biotechnol       Date:  2017-09-11       Impact factor: 54.908

Review 3.  The advent of AAV9 expands applications for brain and spinal cord gene delivery.

Authors:  Robert D Dayton; David B Wang; Ronald L Klein
Journal:  Expert Opin Biol Ther       Date:  2012-04-20       Impact factor: 4.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.